author_facet Azpiroz, Fernando
Molne, Laura
Mendez, Sara
Nieto, Adoración
Manichanh, Chaysavanh
Mego, Marianela
Accarino, Anna
Santos, Javier
Sailer, Manuela
Theis, Stephan
Guarner, Francisco
Azpiroz, Fernando
Molne, Laura
Mendez, Sara
Nieto, Adoración
Manichanh, Chaysavanh
Mego, Marianela
Accarino, Anna
Santos, Javier
Sailer, Manuela
Theis, Stephan
Guarner, Francisco
author Azpiroz, Fernando
Molne, Laura
Mendez, Sara
Nieto, Adoración
Manichanh, Chaysavanh
Mego, Marianela
Accarino, Anna
Santos, Javier
Sailer, Manuela
Theis, Stephan
Guarner, Francisco
spellingShingle Azpiroz, Fernando
Molne, Laura
Mendez, Sara
Nieto, Adoración
Manichanh, Chaysavanh
Mego, Marianela
Accarino, Anna
Santos, Javier
Sailer, Manuela
Theis, Stephan
Guarner, Francisco
Journal of Clinical Gastroenterology
Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
Gastroenterology
author_sort azpiroz, fernando
spelling Azpiroz, Fernando Molne, Laura Mendez, Sara Nieto, Adoración Manichanh, Chaysavanh Mego, Marianela Accarino, Anna Santos, Javier Sailer, Manuela Theis, Stephan Guarner, Francisco 0192-0790 Ovid Technologies (Wolters Kluwer Health) Gastroenterology http://dx.doi.org/10.1097/mcg.0000000000000723 <jats:sec> <jats:title>Goal:</jats:title> <jats:p>To determine the effect of a prebiotic chicory-derived inulin-type fructan on the tolerance of intestinal gas.</jats:p> </jats:sec> <jats:sec> <jats:title>Background:</jats:title> <jats:p>Subjects with gas-related complaints exhibit impaired handling of intestinal gas loads and we hypothesized that inulin would have a beneficial effect.</jats:p> </jats:sec> <jats:sec> <jats:title>Study:</jats:title> <jats:p>Placebo-controlled, parallel, randomized, double-blind trial. Subjects with abdominal symptoms and reduced tolerance of intestinal gas (selected by a pretest) received either inulin (8 g/d, n=18) or maltodextrin as a placebo (8 g/d, n=18) for 4 weeks. A gas challenge test (4 h jejunal gas infusion at 12 mL/min while measuring abdominal symptoms and gas retention for 3 h) was performed before and at the end of the intervention phase. Gastrointestinal symptoms and bowel habits (using daily questionnaires for 1 wk) and fecal bifidobacteria counts were measured before and at the end of the intervention.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p>Inulin decreased gas retention during the gas challenge test (by 22%; <jats:italic toggle="yes">P</jats:italic>=0.035 <jats:italic toggle="yes">vs.</jats:italic> baseline), while the placebo did not, but the intergroup difference was not statistically significant (<jats:italic toggle="yes">P</jats:italic>=0.343). Inulin and placebo reduced the perception of abdominal sensations in the gas challenge test to a similar extent (by 52% and 43%, respectively). Participants reported moderate gastrointestinal symptoms and normal bowel habits during baseline examination, and these findings remained unchanged in both groups during the intervention. Inulin led to a higher relative abundance of bifidobacteria counts (<jats:italic toggle="yes">P</jats:italic>=0.01 vs. placebo).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions:</jats:title> <jats:p>A daily dose of inulin that promotes bifidobacteria growth and may improve gut function, is well tolerated by subjects with gastrointestinal complaints.</jats:p> </jats:sec> Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function Journal of Clinical Gastroenterology
doi_str_mv 10.1097/mcg.0000000000000723
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny9tY2cuMDAwMDAwMDAwMDAwMDcyMw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny9tY2cuMDAwMDAwMDAwMDAwMDcyMw
institution DE-Gla1
DE-Zi4
DE-15
DE-Rs1
DE-Pl11
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
imprint Ovid Technologies (Wolters Kluwer Health), 2017
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2017
issn 0192-0790
issn_str_mv 0192-0790
language English
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
match_str azpiroz2017effectofchicoryderivedinulinonabdominalsensationsandbowelmotorfunction
publishDateSort 2017
publisher Ovid Technologies (Wolters Kluwer Health)
recordtype ai
record_format ai
series Journal of Clinical Gastroenterology
source_id 49
title Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_unstemmed Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_full Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_fullStr Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_full_unstemmed Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_short Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_sort effect of chicory-derived inulin on abdominal sensations and bowel motor function
topic Gastroenterology
url http://dx.doi.org/10.1097/mcg.0000000000000723
publishDate 2017
physical 619-625
description <jats:sec> <jats:title>Goal:</jats:title> <jats:p>To determine the effect of a prebiotic chicory-derived inulin-type fructan on the tolerance of intestinal gas.</jats:p> </jats:sec> <jats:sec> <jats:title>Background:</jats:title> <jats:p>Subjects with gas-related complaints exhibit impaired handling of intestinal gas loads and we hypothesized that inulin would have a beneficial effect.</jats:p> </jats:sec> <jats:sec> <jats:title>Study:</jats:title> <jats:p>Placebo-controlled, parallel, randomized, double-blind trial. Subjects with abdominal symptoms and reduced tolerance of intestinal gas (selected by a pretest) received either inulin (8 g/d, n=18) or maltodextrin as a placebo (8 g/d, n=18) for 4 weeks. A gas challenge test (4 h jejunal gas infusion at 12 mL/min while measuring abdominal symptoms and gas retention for 3 h) was performed before and at the end of the intervention phase. Gastrointestinal symptoms and bowel habits (using daily questionnaires for 1 wk) and fecal bifidobacteria counts were measured before and at the end of the intervention.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p>Inulin decreased gas retention during the gas challenge test (by 22%; <jats:italic toggle="yes">P</jats:italic>=0.035 <jats:italic toggle="yes">vs.</jats:italic> baseline), while the placebo did not, but the intergroup difference was not statistically significant (<jats:italic toggle="yes">P</jats:italic>=0.343). Inulin and placebo reduced the perception of abdominal sensations in the gas challenge test to a similar extent (by 52% and 43%, respectively). Participants reported moderate gastrointestinal symptoms and normal bowel habits during baseline examination, and these findings remained unchanged in both groups during the intervention. Inulin led to a higher relative abundance of bifidobacteria counts (<jats:italic toggle="yes">P</jats:italic>=0.01 vs. placebo).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions:</jats:title> <jats:p>A daily dose of inulin that promotes bifidobacteria growth and may improve gut function, is well tolerated by subjects with gastrointestinal complaints.</jats:p> </jats:sec>
container_issue 7
container_start_page 619
container_title Journal of Clinical Gastroenterology
container_volume 51
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792346470588874759
geogr_code not assigned
last_indexed 2024-03-01T17:39:52.878Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Effect+of+Chicory-derived+Inulin+on+Abdominal+Sensations+and+Bowel+Motor+Function&rft.date=2017-08-01&genre=article&issn=0192-0790&volume=51&issue=7&spage=619&epage=625&pages=619-625&jtitle=Journal+of+Clinical+Gastroenterology&atitle=Effect+of+Chicory-derived+Inulin+on+Abdominal+Sensations+and+Bowel+Motor+Function&aulast=Guarner&aufirst=Francisco&rft_id=info%3Adoi%2F10.1097%2Fmcg.0000000000000723&rft.language%5B0%5D=eng
SOLR
_version_ 1792346470588874759
author Azpiroz, Fernando, Molne, Laura, Mendez, Sara, Nieto, Adoración, Manichanh, Chaysavanh, Mego, Marianela, Accarino, Anna, Santos, Javier, Sailer, Manuela, Theis, Stephan, Guarner, Francisco
author_facet Azpiroz, Fernando, Molne, Laura, Mendez, Sara, Nieto, Adoración, Manichanh, Chaysavanh, Mego, Marianela, Accarino, Anna, Santos, Javier, Sailer, Manuela, Theis, Stephan, Guarner, Francisco, Azpiroz, Fernando, Molne, Laura, Mendez, Sara, Nieto, Adoración, Manichanh, Chaysavanh, Mego, Marianela, Accarino, Anna, Santos, Javier, Sailer, Manuela, Theis, Stephan, Guarner, Francisco
author_sort azpiroz, fernando
container_issue 7
container_start_page 619
container_title Journal of Clinical Gastroenterology
container_volume 51
description <jats:sec> <jats:title>Goal:</jats:title> <jats:p>To determine the effect of a prebiotic chicory-derived inulin-type fructan on the tolerance of intestinal gas.</jats:p> </jats:sec> <jats:sec> <jats:title>Background:</jats:title> <jats:p>Subjects with gas-related complaints exhibit impaired handling of intestinal gas loads and we hypothesized that inulin would have a beneficial effect.</jats:p> </jats:sec> <jats:sec> <jats:title>Study:</jats:title> <jats:p>Placebo-controlled, parallel, randomized, double-blind trial. Subjects with abdominal symptoms and reduced tolerance of intestinal gas (selected by a pretest) received either inulin (8 g/d, n=18) or maltodextrin as a placebo (8 g/d, n=18) for 4 weeks. A gas challenge test (4 h jejunal gas infusion at 12 mL/min while measuring abdominal symptoms and gas retention for 3 h) was performed before and at the end of the intervention phase. Gastrointestinal symptoms and bowel habits (using daily questionnaires for 1 wk) and fecal bifidobacteria counts were measured before and at the end of the intervention.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p>Inulin decreased gas retention during the gas challenge test (by 22%; <jats:italic toggle="yes">P</jats:italic>=0.035 <jats:italic toggle="yes">vs.</jats:italic> baseline), while the placebo did not, but the intergroup difference was not statistically significant (<jats:italic toggle="yes">P</jats:italic>=0.343). Inulin and placebo reduced the perception of abdominal sensations in the gas challenge test to a similar extent (by 52% and 43%, respectively). Participants reported moderate gastrointestinal symptoms and normal bowel habits during baseline examination, and these findings remained unchanged in both groups during the intervention. Inulin led to a higher relative abundance of bifidobacteria counts (<jats:italic toggle="yes">P</jats:italic>=0.01 vs. placebo).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions:</jats:title> <jats:p>A daily dose of inulin that promotes bifidobacteria growth and may improve gut function, is well tolerated by subjects with gastrointestinal complaints.</jats:p> </jats:sec>
doi_str_mv 10.1097/mcg.0000000000000723
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny9tY2cuMDAwMDAwMDAwMDAwMDcyMw
imprint Ovid Technologies (Wolters Kluwer Health), 2017
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2017
institution DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161
issn 0192-0790
issn_str_mv 0192-0790
language English
last_indexed 2024-03-01T17:39:52.878Z
match_str azpiroz2017effectofchicoryderivedinulinonabdominalsensationsandbowelmotorfunction
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
physical 619-625
publishDate 2017
publishDateSort 2017
publisher Ovid Technologies (Wolters Kluwer Health)
record_format ai
recordtype ai
series Journal of Clinical Gastroenterology
source_id 49
spelling Azpiroz, Fernando Molne, Laura Mendez, Sara Nieto, Adoración Manichanh, Chaysavanh Mego, Marianela Accarino, Anna Santos, Javier Sailer, Manuela Theis, Stephan Guarner, Francisco 0192-0790 Ovid Technologies (Wolters Kluwer Health) Gastroenterology http://dx.doi.org/10.1097/mcg.0000000000000723 <jats:sec> <jats:title>Goal:</jats:title> <jats:p>To determine the effect of a prebiotic chicory-derived inulin-type fructan on the tolerance of intestinal gas.</jats:p> </jats:sec> <jats:sec> <jats:title>Background:</jats:title> <jats:p>Subjects with gas-related complaints exhibit impaired handling of intestinal gas loads and we hypothesized that inulin would have a beneficial effect.</jats:p> </jats:sec> <jats:sec> <jats:title>Study:</jats:title> <jats:p>Placebo-controlled, parallel, randomized, double-blind trial. Subjects with abdominal symptoms and reduced tolerance of intestinal gas (selected by a pretest) received either inulin (8 g/d, n=18) or maltodextrin as a placebo (8 g/d, n=18) for 4 weeks. A gas challenge test (4 h jejunal gas infusion at 12 mL/min while measuring abdominal symptoms and gas retention for 3 h) was performed before and at the end of the intervention phase. Gastrointestinal symptoms and bowel habits (using daily questionnaires for 1 wk) and fecal bifidobacteria counts were measured before and at the end of the intervention.</jats:p> </jats:sec> <jats:sec> <jats:title>Results:</jats:title> <jats:p>Inulin decreased gas retention during the gas challenge test (by 22%; <jats:italic toggle="yes">P</jats:italic>=0.035 <jats:italic toggle="yes">vs.</jats:italic> baseline), while the placebo did not, but the intergroup difference was not statistically significant (<jats:italic toggle="yes">P</jats:italic>=0.343). Inulin and placebo reduced the perception of abdominal sensations in the gas challenge test to a similar extent (by 52% and 43%, respectively). Participants reported moderate gastrointestinal symptoms and normal bowel habits during baseline examination, and these findings remained unchanged in both groups during the intervention. Inulin led to a higher relative abundance of bifidobacteria counts (<jats:italic toggle="yes">P</jats:italic>=0.01 vs. placebo).</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions:</jats:title> <jats:p>A daily dose of inulin that promotes bifidobacteria growth and may improve gut function, is well tolerated by subjects with gastrointestinal complaints.</jats:p> </jats:sec> Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function Journal of Clinical Gastroenterology
spellingShingle Azpiroz, Fernando, Molne, Laura, Mendez, Sara, Nieto, Adoración, Manichanh, Chaysavanh, Mego, Marianela, Accarino, Anna, Santos, Javier, Sailer, Manuela, Theis, Stephan, Guarner, Francisco, Journal of Clinical Gastroenterology, Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function, Gastroenterology
title Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_full Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_fullStr Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_full_unstemmed Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_short Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
title_sort effect of chicory-derived inulin on abdominal sensations and bowel motor function
title_unstemmed Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
topic Gastroenterology
url http://dx.doi.org/10.1097/mcg.0000000000000723